Thermo Fisher opens 0M Massachusetts facility to expand bioproduction capacity
Sundry Photography Thermo Fisher Scientific (NYSE:TMO) said on Sept. 20 that it opened a $160M facility in Chelmsford, Massachusetts for biologic m...
Sundry Photography Thermo Fisher Scientific (NYSE:TMO) said on Sept. 20 that it opened a $160M facility in Chelmsford, Massachusetts for biologic materials needed to produce vaccines and therapies for cancer and other diseases. The new 85K-square-foot facility is part of a larger $650M multi-year investment that the Waltham, Mass.-based life sciences company has planned to expand its bioprocessing production capabilities across 11 manufacturing sites in North America, Europe and Asia. The technologies produced at the Chelmsford facility are used in the purification process of developing biotherapeutics and vaccines, Thermo Fisher said in a Sept.